Instil Bio, Inc. — Income Charts
8 quarters of history · ending 2021-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D↑+315.5% +$32M
$43M
D&A↑+503.4% +$745K
$893K
Operating Income↓-458.0% -$35M
$-43M
EBITDA↑+503.4% +$745K
$893K
Interest Expense
$0
Other Income/Expense↓-242.3% -$1M
$-639K
Pretax Income↓-501.3% -$36M
$-44M
Tax Provision↑+361.6% +$546K
$697K
Net Income↓-492.2% -$36M
$-43M
Operating Margin
-14828.8%
Net Margin
-13965.4%
Effective Tax Rate↑+1.5pts
1.5%
Deferred Tax Liabilities↓-61.5% -$2M
$951K
ETR (Continuing Operations)↑+0.4pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
—
ETR Foreign Differential (pp)
—
Operating Lease Cost↑+300.0% +$900K
$1M
Revenue YoY Variation
-100.0%
Income YoY Variation
-458.0%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↑+46.3pts
-21.6%